Literature DB >> 2070145

High dose busulfan and seizures.

R De La Camara1, J F Tomas, A Figuera, M Berberana, J M Fernandez-Rañada.   

Abstract

Three cases of busulfan-associated convulsions in 28 bone marrow transplant recipients are reported. Convulsions occurred in spite of anticonvulsant prophylaxis in two of the three cases. Fits were generalized; no neurological deficit was found after the episodes and there were no recurrences. Although conditioning regimens including busulfan are used increasingly only rare cases have been reported and little mention of this side effect is made. We emphasize that convulsions are not infrequent side effect of conditioning regimens including high dose busulfan, and efficient anticonvulsant prophylactic regimens should be used.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070145

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  The role of busulfan in bone marrow transplantation.

Authors:  M Hassan
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

2.  Minimal incidence of neurotoxicity without prophylaxis during busulfan-based conditioning regimen in patients undergoing stem cell transplantation.

Authors:  Eucario Leon-Rodriguez; Monica M Rivera-Franco
Journal:  Int J Hematol       Date:  2016-10-08       Impact factor: 2.490

3.  Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

Authors:  M Hassan; G Oberg; M Björkholm; I Wallin; M Lindgren
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 4.  Busulfan in hematopoietic stem cell transplantation.

Authors:  Stefan O Ciurea; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2009-02-12       Impact factor: 5.742

5.  Clonazepam for seizure prophylaxis in adult patients treated with high dose busulfan.

Authors:  Maria Sacramento Diaz-Carrasco; Raquel Olmos; Miguel Blanquer; Javier Velasco; Andrés Sánchez-Salinas; José María Moraleda
Journal:  Int J Clin Pharm       Date:  2013-04-11

6.  Neurologic Complications of Bone Marrow and Stem-cell Transplantation in Patients with Cancer.

Authors:  Rose Marie Mathew; Myrna R Rosenfeld
Journal:  Curr Treat Options Neurol       Date:  2007-07       Impact factor: 3.972

7.  Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients.

Authors:  Kana Akiyama; Tetsuo Kume; Masafumi Fukaya; Ikue Shiki; Terukazu Enami; Raine Tatara; Michihiro Shino; Takashi Ikeda
Journal:  Cancer Chemother Pharmacol       Date:  2018-08-06       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.